www.theepochtimes.com Open in urlscan Pro
2606:4700::6811:9e16  Public Scan

URL: https://www.theepochtimes.com/health/study-of-nearly-100-million-covid-19-vaccine-recipients-reveals-a-host-of-adverse-events-...
Submission: On February 26 via manual from US — Scanned from DE

Form analysis 0 forms found in the DOM

Text Content

AD
Share This Article,  Friends Read Free

1962336

HealthCOVID-19COVID Vaccines



CDC-FUNDED STUDY OF NEARLY 100 MILLION COVID-19 VACCINE RECIPIENTS REVEALS A
HOST OF ADVERSE EVENTS

Cases of a blood clot condition called CVST were found to be three times higher
than expected among the vaccinated.

A health care worker fills a syringe with Pfizer's COVID-19 vaccine in a file
image. (Robyn Beck/AFP via Getty Images)
By Naveen Athrappully
2/19/2024
Updated:
2/21/2024

Print
X 1

0:00




A multinational study of over 99 million vaccinated people has identified higher
incidences of neurological, cardiovascular, and blood disorder complications
than what the researchers expected.

The peer-reviewed observational cohort study, published in the Vaccine journal
on Feb. 12, aimed to evaluate the risk of 13 adverse events of special interest
(AESI) following COVID-19 vaccination. The AESIs spanned three
categories—neurological, hematologic (blood), and cardiovascular.

It reviewed data collected from more than 99 million vaccinated people from
eight nations—Argentina, Australia, Canada, Denmark, Finland, France, New
Zealand, and Scotland—looking at risks up to 42 days after getting the shots.

Story continues below advertisement






The study looked at three vaccines—Pfizer and Moderna’s mRNA vaccines as well as
AstraZeneca’s viral vector jab.

Researchers found higher than expected cases that they deemed met the threshold
to be potential safety signals for multiple AESIs, including for Guillain-Barre
syndrome (GBS), cerebral venous sinus thrombosis (CVST), myocarditis, and
pericarditis. A safety signal refers to information that could suggest a
potential risk or harm that may be associated with a medical product.
 * GBS is a disorder in which a body’s immune system attacks the nerves, and can
   eventually paralyze the whole body. Most people with the condition require
   hospitalization. A “statistically significant increase” in GBS cases was
   observed after the first AstraZeneca shot. The researchers had expected 76
   GBS events in the observational cohort study but ended up identifying 190.
 * Acute disseminated encephalomyelitis (ADEM) is a condition that typically
   occurs after a bacterial or viral infection. It causes inflammation of the
   central nervous system. Two cases were expected. However, the study
   identified seven events after the first Moderna jab.
 * Bell’s palsy is a weakness or paralysis of facial muscles. Higher than
   expected Bell’s palsy cases were identified after the first dose of the
   Pfizer and Moderna vaccines.
 * CVST is a condition in which blood clots form in the brain, blocking the
   blood from draining out. This can end up causing a hemorrhage. While 21
   events were expected, researchers identified over three times the number of
   cases at 69 following the first dose of AstraZeneca vaccine. CVST cases were
   also higher than expected after the first and second Pfizer shots.
 * Myocarditis is inflammation of the heart muscle. Higher than expected cases
   of myocarditis that met the threshold for “prioritized safety signals” for
   the condition were “consistently identified following a first, second, and
   third dose of mRNA vaccines,” both Pfizer and Moderna, according to the
   study.
 * Pericarditis is an inflammation of the outer lining of the heart. The number
   of pericarditis cases exceeded expectations following “all doses of all the
   three vaccines,” researchers wrote.


COMMENTARY FROM RESEARCHERS

The higher risk of GBS from vector-based vaccines like AstraZeneca has been
identified in other studies as well, the researchers pointed out. Interestingly,
studies on mRNA vaccines “have not observed increases of GBS,” they noted.

The researchers said that multiple other studies have also identified “increased
incidence of CVST after vaccination,” which has led to the withdrawal of
AstraZeneca vaccine from COVID-19 vaccine programs in several nations. Some
countries have imposed age-based restrictions for the shot, they added.

Related Stories
COVID Vaccine mRNA Can ‘Spread Systemically’ to Placenta and Infants of Women
Vaccinated During Pregnancy
2/19/2024

One-Third of Doctors, Half of Nurses in Canada Were Reluctant to Take COVID
Vaccines: Government Survey
2/19/2024

Regarding myocarditis and pericarditis, researchers noted that the World Health
Organization (WHO) has issued guidance on the conditions. A 2021 guidance from
the WHO stated at the time that more countries were “reporting myocarditis and
pericarditis in individuals who received COVID-19 mRNA vaccines.”

The Feb. 12 study noted that the U.S. Centers for Disease Control and Prevention
(CDC) is monitoring and reviewing data on myocarditis and pericarditis among
COVID-19 vaccinated individuals.

The study was funded by the Centers for Disease Control and Prevention (CDC),
Public Health Ontario, ICES which is funded by the Ontario Ministry of Health,
as well as a Clinician-Scientist Award from the University of Toronto Department
of Family and Community Medicine. Researchers declared several potential
competing interests.


The Epoch Times reached out to Moderna, Pfizer, and AstraZeneca for comment
regarding the study.


RECENT STUDIES IMPLY VACCINE DANGERS

Numerous studies have shown that COVID-19 vaccines come with a risk of multiple
medical complications. A recent Feb. 15 study conducted in Nordic nations
concluded that booster vaccination against COVID-19 is linked to a higher risk
of heart inflammation among adolescents.

The study noted that the association of myocarditis with COVID-19 mRNA vaccines
has appeared “strongest in male adolescents and younger males and after the
second dose.”

A separate Jan. 27 study points out that a “considerable body of evidence”
suggests a correlation and even a causation between mRNA boosters and adverse
effects on the immune system.

“Given the decreased severity of the virus … there are legitimate concerns about
the frequent administration of boosters in immunocompromised patients, raising
questions about whether this practice may be causing more harm than benefit,” it
said.

A study accepted into the American Journal of Obstetrics and Gynecology on Jan.
24 (pdf) investigated placenta samples from two pregnant women who had received
Pfizer and Moderna vaccines. Researchers concluded that “vaccine mRNA is not
localized to the injection site and can spread systemically to the placenta and
umbilical cord blood.”
Commenting on the study, cardiologist Peter McCullough said that the
observations “have confirmed one of our worst fears, that is, poorly advised
vaccination during pregnancy allows circulating mRNA and local production of
Spike protein in the placenta potentially threatening the gestation and
delivery.”

“But worse, mRNA is passed on to the baby with unknown effects on organogenesis,
tissue damage, blood clotting, and a host of other adverse processes within the
newborn’s body.”

A peer-reviewed article from last month which analyzed reports from the initial
phase 3 trials of Pfizer and Moderna COVID-19 vaccines concluded that the shots
killed more people than they saved.

Based on “conservative assumptions,“ the estimated harms of the COVID-19 mRNA
vaccines ”greatly outweigh the rewards,“ the article stated, noting that ”for
every life saved, there were nearly 14 times more deaths caused by the modified
mRNA injections.”

Lately, evidence has been mounting suggesting the “shedding” of COVID-19 vaccine
proteins. The controversial subject was largely discounted by scientists but now
some doctors say that authorities are well aware of the phenomenon.

1962
Friends Read Free
Copy
Comments
Write a comment...
Top Two Comments:
John Schubert

2024-02-20

I decided not to take the Covid vaccine based on 2 deaths of friends of friends.
One was a 39 year old woman in perfect health, the other was an elderly man.
My children were but in collage and they were required to take it or resign.
My big problem is people should be able to assess the risk and make up their own
minds not be forced to do something they think is dangerous.

Reply

Share

Brodie Brock

2024-02-20

Greatest CON and CRIME in the history of man and it was all just “allowed” to
occur and still is. Not ONE person responsible for it all has remotely been held
accountable. Not ONE person on the entire planet earth. Think about that
considering what was done and what we have seen and KNOW. Not ONE!

Reply

Share

336
Comments


HEALTH

1


STUDY FINDS HEARING AND BALANCE DISORDERS AMONG COVID-19 VACCINATED


2


CDC DATA: NOROVIRUS CASES ON THE RISE IN THE US, NAMELY THE NORTHEAST


3


STUDY FINDS INCREASING TIME BETWEEN COVID VACCINE DOSES REDUCES RISK OF
MYOCARDITIS, YET CARDIOLOGISTS RAISE CONCERNS


4


PSYCHOLOGICAL THERAPIES MAY RELIEVE INFLAMMATORY BOWEL DISEASE


5


WRITTEN OFF: THE CONSEQUENCES OF DEMENTIA MISDIAGNOSIS




POPULAR NEWS

1


TOP REPUBLICAN REVEALS NEW ‘WHISTLEBLOWER’ IN FANI WILLIS’S OFFICE


2


RONNA MCDANIEL OFFICIALLY ANNOUNCES RESIGNATION AS RNC CHAIR


3


KOCH NETWORK WITHDRAWS FINANCIAL SUPPORT FOR NIKKI HALEY


4


SUPREME COURT ALLOWS DISPUTE OVER WASHINGTON LEGISLATIVE DISTRICT TO CONTINUE


5


BULK OF REPUBLICANS LOCKED IN ON SUPPORT FOR TRUMP


Share it now
Naveen Athrappully
Author


Follow
Naveen Athrappully is a news reporter covering business and world events at The
Epoch Times.


Author’s Selected Articles


DARTMOUTH, NORTHWESTERN, RICE, VANDERBILT UNIVERSITIES AGREE TO $166 MILLION
SETTLEMENT IN PRICE-FIXING LAWSUIT

Feb 25, 2024




US, UK LEAD RETALIATORY STRIKE AGAINST HOUTHIS IN YEMEN

Feb 25, 2024




STUDY FINDS HEARING AND BALANCE DISORDERS AMONG COVID-19 VACCINATED

Feb 25, 2024



MOTHERS SUE MERCK ALLEGING WRONGFUL DEATHS OF DAUGHTERS FROM HPV VACCINE

Feb 24, 2024

Related Topics
COVID-19 vaccination
myocarditis
covid-19 vaccine adverse events
Comments
Write a comment...
Top Two Comments:
John Schubert

2024-02-20

I decided not to take the Covid vaccine based on 2 deaths of friends of friends.
One was a 39 year old woman in perfect health, the other was an elderly man.
My children were but in collage and they were required to take it or resign.
My big problem is people should be able to assess the risk and make up their own
minds not be forced to do something they think is dangerous.

Reply

Share

Brodie Brock

2024-02-20

Greatest CON and CRIME in the history of man and it was all just “allowed” to
occur and still is. Not ONE person responsible for it all has remotely been held
accountable. Not ONE person on the entire planet earth. Think about that
considering what was done and what we have seen and KNOW. Not ONE!

Reply

Share



AROUND THE WEB



WIE VIEL KOSTET DIE INSTALLATION VON SOLARMODULEN IM {СITY}? (PRÜFEN SIE HIER)

Sonnenkollektoren billig

HAARTRANSPLANTATION (HIER ANSEHEN)

Haartransplantationen

THIS VIDEO WILL SOON BE BANNED. WATCH BEFORE IT'S DELETED

Secrets Revealed

DIES SIND BÄDER EINER NEUEN GENERATION. TIPPEN ZUM ANSEHEN

Bad Komplettsanierung

NEW SENIOR APARTMENTS IN FRANKFURT AM MAIN - TAKE A LOOK!

Senior Living | Search Ads

KNIEARTHROSE? EINE EINFACHE METHODE BEHANDLUNG OHNE OPERATION

Knee Osteoarthritis Treatment
Load More

From Our Partners
These 5 Kirkland Products at Costco Are Made by Brands You Know and Love
Cause of Death for Suzanne Somers Is In
Costco’s Latest Bakery Addition Takes Decadence to a New Level
Tucker is Outing Obama as Gay. But Everyone is Missing the Big Story.
Joe Biden’s Pick to Head Social Security Wants to Make These Changes
Here's How Much Social Security Income Joe Biden Collects




EPOCH HEALTH


Explore Our Health Newsletters
Get the best in health and wellness. See all of our inspiring newsletter.
Choose Yours Now
NewslettersHealth: Rise & ShineWellness: Mind, Body & Soul21-Day Super Immunity
ChallengeGut HealthArthritis & Chronic PainVaccine InvestigationIntegrative
MedicineNutrition & SupplementsAging Well
The Essential GuideHeart DiseaseParkinson’s
DiseaseCancerTinnitusArthritisAlzheimer’s DiseaseAnxietyMigrainesKidney Disease
SpecialOriginal SeriesThe Essential GuideBooksBrain GamesChallenge
Newsletters
The Essential Guide
Special
The content in Epoch Health is not intended to be a substitute for professional
medical advice, diagnosis or treatment. Never disregard professional medical
advice, or delay in seeking it, because of something you have read in this
publication. Never rely on information in this publication in place of seeking
professional medical advice. Epoch Health does not recommend or endorse any
specific tests, products, procedures, opinions or other information that may be
provided in this publication.See additional information.
Contact UsMedia StatementsAbout UsRSS FeedsTerms of ServicesPrivacy
PolicyCopyright PolicyData DisclaimerDigital NewspaperOur StorySubscribeCareers
Copyright © 2000 - 2024 The Epoch Times Association Inc. All Rights Reserved.
Manage Preferences




WE CARE ABOUT YOUR PRIVACY

We use cookies on our website to improve your browsing experience. We and our
798 partners store and access personal information on your device such as
browsing data to gain insight into how the site is being used. You can control
your cookie preferences at any time by clicking on the 'Manage Preferences'
button.


WE AND OUR PARTNERS PROCESS DATA TO PROVIDE:

Use precise geolocation data. Actively scan device characteristics for
identification. Store and/or access information on a device. Personalised
advertising and content, advertising and content measurement, audience research
and services development. List of Partners (vendors)

Reject All I Accept
Manage Preferences



Your Opt Out Preference Signal is Honored


ABOUT YOUR PRIVACY

We process your data to deliver content or advertisements and measure the
delivery of such content or advertisements to extract insights about our
website. We share this information with our partners on the basis of consent.
You may exercise your right to consent, based on a specific purpose below or at
a partner level in the link under each purpose. These choices will be signaled
to our vendors participating in the Transparency and Consent Framework.
More information
Allow All


MANAGE CONSENT PREFERENCES

FUNCTIONAL COOKIES

Functional Cookies

These cookies enable the website to provide enhanced functionality and
personalisation. They may be set by us or by third party providers whose
services we have added to our pages. If you do not allow these cookies then some
or all of these services may not function properly.

PERFORMANCE COOKIES

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They help us to know which pages are the
most and least popular and see how visitors move around the site. All
information these cookies collect is aggregated and therefore anonymous. If you
do not allow these cookies we will not know when you have visited our site, and
will not be able to monitor its performance.

TARGETING COOKIES

Targeting Cookies

These cookies may be set through our site by our advertising partners. They may
be used by those companies to build a profile of your interests and show you
relevant adverts on other sites. They do not store directly personal
information, but are based on uniquely identifying your browser and internet
device. If you do not allow these cookies, you will experience less targeted
advertising.

STRICTLY NECESSARY COOKIES

Always Active

These cookies are necessary for the website to function and cannot be switched
off in our systems. They are usually only set in response to actions made by you
which amount to a request for services, such as setting your privacy
preferences, logging in or filling in forms. You can set your browser to block
or alert you about these cookies, but some parts of the site will not then work.
These cookies do not store any personally identifiable information.

STORE AND/OR ACCESS INFORMATION ON A DEVICE 652 PARTNERS CAN USE THIS PURPOSE

Store and/or access information on a device

Cookies, device or similar online identifiers (e.g. login-based identifiers,
randomly assigned identifiers, network based identifiers) together with other
information (e.g. browser type and information, language, screen size, supported
technologies etc.) can be stored or read on your device to recognise it each
time it connects to an app or to a website, for one or several of the purposes
presented here.

List of IAB Vendors‎ | View Illustrations 

PERSONALISED ADVERTISING AND CONTENT, ADVERTISING AND CONTENT MEASUREMENT,
AUDIENCE RESEARCH AND SERVICES DEVELOPMENT 767 PARTNERS CAN USE THIS PURPOSE

Personalised advertising and content, advertising and content measurement,
audience research and services development

 * USE LIMITED DATA TO SELECT ADVERTISING 592 PARTNERS CAN USE THIS PURPOSE
   
   Switch Label
   
   Advertising presented to you on this service can be based on limited data,
   such as the website or app you are using, your non-precise location, your
   device type or which content you are (or have been) interacting with (for
   example, to limit the number of times an ad is presented to you).
   
   View Illustrations 

 * CREATE PROFILES FOR PERSONALISED ADVERTISING 486 PARTNERS CAN USE THIS
   PURPOSE
   
   Switch Label
   
   Information about your activity on this service (such as forms you submit,
   content you look at) can be stored and combined with other information about
   you (for example, information from your previous activity on this service and
   other websites or apps) or similar users. This is then used to build or
   improve a profile about you (that might include possible interests and
   personal aspects). Your profile can be used (also later) to present
   advertising that appears more relevant based on your possible interests by
   this and other entities.
   
   View Illustrations 

 * USE PROFILES TO SELECT PERSONALISED ADVERTISING 479 PARTNERS CAN USE THIS
   PURPOSE
   
   Switch Label
   
   Advertising presented to you on this service can be based on your advertising
   profiles, which can reflect your activity on this service or other websites
   or apps (like the forms you submit, content you look at), possible interests
   and personal aspects.
   
   View Illustrations 

 * CREATE PROFILES TO PERSONALISE CONTENT 213 PARTNERS CAN USE THIS PURPOSE
   
   Switch Label
   
   Information about your activity on this service (for instance, forms you
   submit, non-advertising content you look at) can be stored and combined with
   other information about you (such as your previous activity on this service
   or other websites or apps) or similar users. This is then used to build or
   improve a profile about you (which might for example include possible
   interests and personal aspects). Your profile can be used (also later) to
   present content that appears more relevant based on your possible interests,
   such as by adapting the order in which content is shown to you, so that it is
   even easier for you to find content that matches your interests.
   
   View Illustrations 

 * USE PROFILES TO SELECT PERSONALISED CONTENT 185 PARTNERS CAN USE THIS PURPOSE
   
   Switch Label
   
   Content presented to you on this service can be based on your content
   personalisation profiles, which can reflect your activity on this or other
   services (for instance, the forms you submit, content you look at), possible
   interests and personal aspects, such as by adapting the order in which
   content is shown to you, so that it is even easier for you to find
   (non-advertising) content that matches your interests.
   
   View Illustrations 

 * MEASURE ADVERTISING PERFORMANCE 683 PARTNERS CAN USE THIS PURPOSE
   
   Switch Label
   
   Information regarding which advertising is presented to you and how you
   interact with it can be used to determine how well an advert has worked for
   you or other users and whether the goals of the advertising were reached. For
   instance, whether you saw an ad, whether you clicked on it, whether it led
   you to buy a product or visit a website, etc. This is very helpful to
   understand the relevance of advertising campaigns.
   
   View Illustrations 

 * MEASURE CONTENT PERFORMANCE 343 PARTNERS CAN USE THIS PURPOSE
   
   Switch Label
   
   Information regarding which content is presented to you and how you interact
   with it can be used to determine whether the (non-advertising) content e.g.
   reached its intended audience and matched your interests. For instance,
   whether you read an article, watch a video, listen to a podcast or look at a
   product description, how long you spent on this service and the web pages you
   visit etc. This is very helpful to understand the relevance of
   (non-advertising) content that is shown to you.
   
   View Illustrations 

 * UNDERSTAND AUDIENCES THROUGH STATISTICS OR COMBINATIONS OF DATA FROM
   DIFFERENT SOURCES 428 PARTNERS CAN USE THIS PURPOSE
   
   Switch Label
   
   Reports can be generated based on the combination of data sets (like user
   profiles, statistics, market research, analytics data) regarding your
   interactions and those of other users with advertising or (non-advertising)
   content to identify common characteristics (for instance, to determine which
   target audiences are more receptive to an ad campaign or to certain
   contents).
   
   View Illustrations 

 * DEVELOP AND IMPROVE SERVICES 515 PARTNERS CAN USE THIS PURPOSE
   
   Switch Label
   
   Information about your activity on this service, such as your interaction
   with ads or content, can be very helpful to improve products and services and
   to build new products and services based on user interactions, the type of
   audience, etc. This specific purpose does not include the development or
   improvement of user profiles and identifiers.
   
   View Illustrations 

 * USE LIMITED DATA TO SELECT CONTENT 110 PARTNERS CAN USE THIS PURPOSE
   
   Switch Label
   
   Content presented to you on this service can be based on limited data, such
   as the website or app you are using, your non-precise location, your device
   type, or which content you are (or have been) interacting with (for example,
   to limit the number of times a video or an article is presented to you).
   
   View Illustrations 

List of IAB Vendors‎

USE PRECISE GEOLOCATION DATA 256 PARTNERS CAN USE THIS PURPOSE

Use precise geolocation data

With your acceptance, your precise location (within a radius of less than 500
metres) may be used in support of the purposes explained in this notice.

List of IAB Vendors‎

ACTIVELY SCAN DEVICE CHARACTERISTICS FOR IDENTIFICATION 116 PARTNERS CAN USE
THIS PURPOSE

Actively scan device characteristics for identification

With your acceptance, certain characteristics specific to your device might be
requested and used to distinguish it from other devices (such as the installed
fonts or plugins, the resolution of your screen) in support of the purposes
explained in this notice.

List of IAB Vendors‎

ENSURE SECURITY, PREVENT AND DETECT FRAUD, AND FIX ERRORS 488 PARTNERS CAN USE
THIS PURPOSE

Always Active

Your data can be used to monitor for and prevent unusual and possibly fraudulent
activity (for example, regarding advertising, ad clicks by bots), and ensure
systems and processes work properly and securely. It can also be used to correct
any problems you, the publisher or the advertiser may encounter in the delivery
of content and ads and in your interaction with them.

List of IAB Vendors‎ | View Illustrations 

DELIVER AND PRESENT ADVERTISING AND CONTENT 475 PARTNERS CAN USE THIS PURPOSE

Always Active

Certain information (like an IP address or device capabilities) is used to
ensure the technical compatibility of the content or advertising, and to
facilitate the transmission of the content or ad to your device.

List of IAB Vendors‎ | View Illustrations 

MATCH AND COMBINE DATA FROM OTHER DATA SOURCES 338 PARTNERS CAN USE THIS PURPOSE

Always Active

Information about your activity on this service may be matched and combined with
other information relating to you and originating from various sources (for
instance your activity on a separate online service, your use of a loyalty card
in-store, or your answers to a survey), in support of the purposes explained in
this notice.

List of IAB Vendors‎

LINK DIFFERENT DEVICES 316 PARTNERS CAN USE THIS PURPOSE

Always Active

In support of the purposes explained in this notice, your device might be
considered as likely linked to other devices that belong to you or your
household (for instance because you are logged in to the same service on both
your phone and your computer, or because you may use the same Internet
connection on both devices).

List of IAB Vendors‎

IDENTIFY DEVICES BASED ON INFORMATION TRANSMITTED AUTOMATICALLY 459 PARTNERS CAN
USE THIS PURPOSE

Always Active

Your device might be distinguished from other devices based on information it
automatically sends when accessing the Internet (for instance, the IP address of
your Internet connection or the type of browser you are using) in support of the
purposes exposed in this notice.

List of IAB Vendors‎
Back Button


COOKIE LIST



Search Icon
Filter Icon

Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label

Reject All Confirm My Choices